Pazoo, Inc. is a company focused on health, wellness and safety. Through our involvement in the burgeoning medical cannabis industry, our mission is to provide best-in-class laboratory testing of cannabis and cannabinoids to ensure quality and consistency that protects consumers from impurities, contaminants and other irregularities. Pazoo’s wholly-owned subsidiary, Harris Lee, and 40%-owned MA & Associates, offer industry-leading laboratory testing and analytics via an exclusive licensing agreement with global testing leader Steep Hill Labs, Inc. Pazoo's contract with Steep Hill allows us to use their premier, proprietary testing protocols on a right-of-first-refusal basis as we expand throughout the U.S. Pazoo is licensed to test cannabis in Nevada and Oregon, with a strategy of expansion into other states.
Additionally, Pazoo delivers a comprehensive array of empowering health and wellness information for people and their pets on its robust website, www.pazoo.com, featuring industry experts from both the health and wellness arena and pet care industry.
Market Value: $5,317,254 a/o Sep 04, 2015
Authorized Shares: 980,000,000 a/o Apr 22, 2015
Outstanding Shares: 728,390,950 a/o Aug 19, 2015
Float: 449,536,555 a/o Apr 22, 2015
Shareholders of Record: 203 a/o Apr 22, 2015
Short Interest: 505,381 (91.78%) Aug 14, 2015
Transfer Agent: VStock Transfer, LLC
David M. Cunic - CEO, Director
Steven Basloe - Chairman of the Board, President, Executive Vice President of Marketing and Sales
Ben Hoehn - COO, CFO
Gregory Jung - Chief Financial Officer, Director